Chiasma Inc. | Key People and Executives
Mark J. Fitzpatrick
President, Chief Executive Officer & Director
Bard J. Geesaman
Independent Director
John A. Scarlett
Independent Director
Todd T. Foley
Independent Director
Scott Minick
Independent Director
John F. Thero
Independent Director
Mark J. Fitzpatrick
President, Chief Executive Officer & Director
Drew Enamait
Principal Accounting Officer & VP-Finance
William Ludlam
Senior VP-Clinical Development & Medical Affairs
Asi Haviv
Vice President-Clinical Development
Dana Gelbaum
VP-Global Marketing & Corporate Development
Shoshie Katz
VP-Quality Assurance & Regulatory Affairs
Bard J. Geesaman
Independent Director
John A. Scarlett
Independent Director
Todd T. Foley
Independent Director
Scott Minick
Independent Director
John F. Thero
Independent Director
| Address |
460 Totten Pond Road
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.chiasmapharma.com |
| Updated |
07/08/2019 |
| Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The company's Transient Permeability Enhancer (TPE) technology platform, seeks to develop oral medications. |
